Age at time of event: 18 years or older.Device is a combination product.Device evaluated by manufacturer - it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
|
It was reported that vessel dissection occurred.Vascular access was obtained via the femoral artery.The target lesion was located in the moderately tortuous mid to distal right coronary artery (rca).After deploying a 3.00mmx24mm (b)(6) drug-eluting stent (des) was deployed in the left anterior descending (lad) artery, predilation was performed in the rca.A 3.00x38mm (b)(6) ¿ long des was then deployed.Post dilation was performed and an edge dissection in the distal part of the stent was then noticed.A 2.75x16 (b)(6) des was then deployed to cover the dissection, overlapping the previously implanted stent.No further patient complications were reported and the patient's status was stable.
|